Bella Intimates

Bella Intimates

New Surgery Guideline for Breast Cancer Patients
Essentially Women • 18 May 2023

New Surgery Guideline for Breast Cancer Patients

2 millimeters is enough to guard against recurrences while reducing need for additional surgeries

New surgery guidelines for certain breast cancer patients could reduce both unnecessary surgeries and recurrence rates, three U.S. cancer groups say. The guideline is for treatment of women with ductal carcinoma in situ (DCIS) who undergo breast-conserving surgery with whole breast radiation. DCIS is an early stage cancer

"The use of a 2-millimeter margin as the standard for an adequate margin in DCIS treated with whole breast radiation therapy is associated with low rates of recurrence of cancer in the breast and has the potential to decrease re-excision rates, improve cosmetic outcome and decrease health care costs," according to the guideline from the Society of Surgical Oncology, the American Society for Radiation Oncology and the American Society of Clinical Oncology.

"Margins more widely clear than 2 millimeters do not further reduce the rates of recurrence of cancer in the breast and their routine use is not supported by evidence," the guidelines stated.

What Signs of Breast Cancer are there other than a Lump
by Essentially Women 18 May 2023
A breast lump or mass is just one of the possible signs of breast cancer in women or men. Breast cancer can cause serveral additional changes to the skin on and around the breast. Anyone who notices any of these changes should see a doctor.
What to Know About Menopause and Sore Breasts
by Essentially Women 18 May 2023
A person reaches menopause after 12 months without having a period. This stage follows a transitional period called perimenopause, where estrogen and progesterone levels in the body fluctuate unpredictably.
New Potential Treatment Option for Triple Negative Breast Cancer
by Essentially Women 18 May 2023
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
View More Articles
Share by: